Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2002

 

OR

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from          to          

 

Commission File Number: 0-30822

 


 

SYNAVANT Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

22-2940965

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

3445 Peachtree Road NE, Suite 1400
Atlanta, GA

 

30326

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code (404) 841-4000

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ý No o

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Title of Class

 

Shares Outstanding
at October 31, 2002

Common Stock,
par value $.01 per share

 

15,179,331 Shares

 

 



 

SYNAVANT Inc.

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2002

 

INDEX

 

PART I.

FINANCIAL INFORMATION

 

 

ITEM 1.

FINANCIAL STATEMENTS

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2002 and December 31, 2001

 

 

 

Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2002 and 2001

 

 

 

Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2002 and 2001

 

 

 

Notes to Consolidated Financial Statements

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 

PART II.

OTHER INFORMATION

 

 

ITEM 1.

LEGAL PROCEEDINGS

 

 

ITEM 2.

CHANGES IN SECURITIES AND USE OF PROCEEDS

 

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

 

ITEM 4.

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

 

ITEM 5.

OTHER INFORMATION

 

 

ITEM 6.

EXHIBITS AND REPORTS ON FORM 8-K

 

 

SIGNATURES

 

2



 

PART I. FINANCIAL INFORMATION

 

ITEM I. FINANCIAL STATEMENTS

 

SYNAVANT Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollar amounts in thousands, except per share data)

 

 

 

 

September 30,
2002

 

December 31,
2001

 

 

 

(Unaudited)

 

(Audited)

 

ASSETS:

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and cash equivalents

 

$

11,446

 

$

9,578

 

Accounts receivable-net

 

35,011

 

39,574

 

Other receivables

 

350

 

209

 

Other current assets

 

6,126

 

6,113

 

TOTAL CURRENT ASSETS

 

52,933

 

55,474

 

 

 

 

 

 

 

Property, plant and equipment-net

 

12,429

 

11,210

 

Computer software-net

 

3,777

 

7,410

 

Goodwill-net

 

41,156

 

41,156

 

Long term notes receivable

 

 

1,000

 

Other assets

 

2,213

 

2,008

 

TOTAL LONG TERM ASSETS

 

59,575

 

62,784

 

TOTAL ASSETS

 

$

112,508

 

$

118,258

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY:

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Accounts payable

 

$

6,941

 

$

9,516

 

Accrued restructuring

 

3,058

 

4,816

 

Accrued and other current liabilities

 

17,111

 

13,289

 

Accrued income taxes

 

2,656

 

1,885

 

Deferred revenues

 

7,805

 

8,388

 

TOTAL CURRENT LIABILITIES

 

37,571

 

37,894

 

 

 

 

 

 

 

Deferred taxes

 

437

 

421

 

Accrued liability due to former parent

 

9,000

 

9,000

 

Other liabilities

 

1,388

 

793

 

TOTAL LIABILITIES

 

$

48,396

 

$

48,108

 

 

 

 

 

 

 

Commitments and contingencies (see note 2)

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

Common stock, par value $.01, authorized 41,000,000 shares; 15,177,101 and 15,059,684 shares outstanding at September 30, 2002 and December 31, 2001, respectively

 

152

 

150

 

Other stockholders’ equity

 

63,960

 

70,000

 

TOTAL STOCKHOLDERS’ EQUITY

 

64,112

 

70,150

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

112,508

 

$

118,258

 

 

See accompanying Notes to the Consolidated Financial Statements (unaudited).

 

3



 

SYNAVANT Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollar amounts in thousands, except per share data)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

REVENUES:

 

 

 

 

 

 

 

 

 

Software fees

 

$

1,678

 

$

1,594

 

$

4,204

 

$

8,765

 

Software services

 

20,059

 

21,123

 

63,015

 

64,873

 

Interactive marketing

 

17,213

 

18,029

 

60,280

 

57,859

 

TOTAL REVENUES

 

38,950

 

40,746

 

127,499

 

131,497

 

 

 

 

 

 

 

 

 

 

 

OPERATING COSTS:

 

 

 

 

 

 

 

 

 

Software fees

 

619

 

1,041

 

2,153

 

4,504

 

Software services

 

13,835

 

15,039

 

44,264

 

49,924

 

Interactive marketing

 

14,960

 

15,101

 

51,083

 

47,930

 

TOTAL OPERATING COSTS

 

29,414

</